High Relapse Rate in Anti-CASPR2 Disease: Implications for Prolonged Immunotherapy.

Brand T, Franken SC, Vermeiren MR, Van Sonderen A, De Bruijn MAAM, Crijnen YS, Brenner J, Kerstens J, Van Steenhoven RW, Sillevis Smitt PAE, Veenbergen S, Roelen DL, Titulaer MJ, de Vries JM.